Tag Archives: Biogazelle

GHENT, Belgium, October 15, 2015 – Biogazelle NV today announced a research-stage collaboration with Isis Pharmaceuticals in which they will identify and validate novel targets to treat colon, liver and lung cancer, diseases with clear unmet clinical needs. As part ...

MicroRNAs (miRNAs) are small non-coding RNA molecules that play a key role in gene expression regulation. They have critical functions in various biological processes and their involvement in disease biology is well documented. Several measurement platforms have been developed to ...

Biogazelle has established a quality management system and is ISO 17025 accredited for gene expression services Biogazelle is a Ghent University spin-off company founded in 2007 by prof. Jo Vandesompele and dr. Jan Hellemans. With a proven track record in ...

Speaker: Dr. Pieter Mestdagh, Ghent University / Biogazelle, Belgium Event: Biogazelle sponsored RNA-sequencing mini-symposium (Ghent – Belgium, Jan. 14, 2015) Genome-wide studies have shown that our genome is pervasively transcribed, producing a complex pool of coding and non-coding transcripts that ...

Project manager wet-lab R and D – transcriptome analysis Project manager dry-lab R and D – transcriptome analysis Our mission Understanding the transcriptome for next generation diagnostics and therapeutics through excellence in science and technology. Project manager wet-lab R and ...

Qbic Arkiv Fund, Foundation Majoie and SOFI invest 2.0 million EUR in UGent spin-off Biogazelle, a company that offers software and laboratory services for gene expression analysis. Biogazelle will primarily use the investment to further develop its research on therapeutic ...